In our recent cross-sectional studies of [11C]UCB-J PET in AD, we observed widespread reductions of SV2A binding in medial temporal and neocortical brain regions in early AD compared to cognitively normal participants [14, 15]. The gene discussed is SV2A; the disease is Alzheimer disease.